Research article
Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study
-
* Corresponding author: Serge D Steinfeld ssteinfe@ulb.ac.be
Arthritis Research & Therapy 2006, 8:R129 doi:10.1186/ar2018
No comments have yet been made on this article.